Current and historical daily PE Ratio for CVSI (
CV Sciences Inc
) from 2011 to Apr 19 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. CV Sciences stock (CVSI) PE ratio as of Apr 19 2024 is 2.17.
More Details
CV Sciences Inc (CVSI) PE Ratio (TTM) Chart
CV Sciences Inc (CVSI) PE Ratio (TTM) Historical Data
View and export this data going back to 2011. Start your Free Trial
Total 1215
- 1
- 2
- 3
- 4
- 5
- 6
- 14
| CV Sciences PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-04-19 | 2.2 | 2024-02-16 | 2.2 |
| 2024-04-18 | 2.2 | 2024-02-15 | 2.2 |
| 2024-04-17 | 2.3 | 2024-02-14 | 2.2 |
| 2024-04-16 | 2.2 | 2024-02-13 | 2.2 |
| 2024-04-15 | 2.2 | 2024-02-12 | 2.2 |
| 2024-04-12 | 2.2 | 2024-02-09 | 2.2 |
| 2024-04-11 | 2.0 | 2024-02-08 | 2.3 |
| 2024-04-10 | 2.3 | 2024-02-07 | 2.4 |
| 2024-04-09 | 2.3 | 2024-02-06 | 2.2 |
| 2024-04-08 | 2.2 | 2024-02-05 | 2.2 |
| 2024-04-05 | 2.4 | 2024-02-02 | 2.2 |
| 2024-04-04 | 2.5 | 2024-02-01 | 2.2 |
| 2024-04-03 | 2.4 | 2024-01-31 | 2.2 |
| 2024-04-02 | 2.3 | 2024-01-30 | 2.2 |
| 2024-04-01 | 2.2 | 2024-01-29 | 2.1 |
| 2024-03-29 | 2.4 | 2024-01-26 | 2.2 |
| 2024-03-28 | 2.4 | 2024-01-25 | 2.2 |
| 2024-03-27 | 2.3 | 2024-01-24 | 2.1 |
| 2024-03-26 | 2.3 | 2024-01-23 | 2.2 |
| 2024-03-25 | 2.3 | 2024-01-22 | 2.2 |
| 2024-03-22 | 2.1 | 2024-01-19 | 2.1 |
| 2024-03-21 | 1.9 | 2024-01-18 | 2.2 |
| 2024-03-20 | 2.1 | 2024-01-17 | 2.1 |
| 2024-03-19 | 2.1 | 2024-01-16 | 2.2 |
| 2024-03-18 | 2.1 | 2024-01-15 | 2.2 |
| 2024-03-15 | 2.0 | 2024-01-12 | 2.2 |
| 2024-03-14 | 2.0 | 2024-01-11 | 2.2 |
| 2024-03-13 | 2.0 | 2024-01-10 | 2.2 |
| 2024-03-12 | 1.8 | 2024-01-09 | 2.1 |
| 2024-03-11 | 1.9 | 2024-01-08 | 2.2 |
| 2024-03-08 | 1.9 | 2024-01-05 | 2.2 |
| 2024-03-07 | 1.9 | 2024-01-04 | 2.2 |
| 2024-03-06 | 1.9 | 2024-01-03 | 2.2 |
| 2024-03-05 | 2.0 | 2024-01-02 | 2.1 |
| 2024-03-04 | 1.9 | 2024-01-01 | 2.1 |
| 2024-03-01 | 2.0 | 2023-12-29 | 2.1 |
| 2024-02-29 | 2.0 | 2023-12-28 | 2.0 |
| 2024-02-28 | 2.0 | 2023-12-27 | 5.3 |
| 2024-02-27 | 1.9 | 2023-12-26 | 5.2 |
| 2024-02-26 | 2.0 | 2023-12-22 | 5.1 |
| 2024-02-23 | 2.0 | 2023-12-21 | 5.1 |
| 2024-02-22 | 2.1 | 2023-12-20 | 5.0 |
| 2024-02-21 | 2.0 | 2023-12-19 | 5.4 |
| 2024-02-20 | 2.1 | 2023-12-18 | 5.4 |
| 2024-02-19 | 2.2 | 2023-12-15 | 5.6 |
CV Sciences Inc (CVSI) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
CV Sciences Inc
NAICS : 325411
SIC : 2833
ISIN : US1266541028
Description
CV Sciences Inc develops, manufactures, markets, and sells herbal supplements and hemp-based cannabidiol. The Company sells its products under tradenames, such as +PlusCBD and PlusCBD Pet. The Company's products are sold in a variety of market sectors including nutraceutical, beauty care, and specialty foods. The company's hemp-based products are predominantly sold in North America and primarily in the retail space. The company generates revenue from Retail Sales and E-Commerce sales of its product.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers